We are live on
!
Find out more
RAM
RWC Asset Management Portfolio holdings
AUM
$2.64B
1-Year Est. Return
33.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.91%
1 Year Est. Return
+33.18%
3 Year Est. Return
+65.38%
5 Year Est. Return
+72.86%
10 Year Est. Return
+395.66%
AUM
$2.64B
AUM Growth
+$241M
(+10%)
Cap. Flow
-$30.7M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
44.58%
Holding
181
New
5
Increased
49
Reduced
33
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
J.M. Smucker
SJM
|
+$158M |
| 2 |
Kraft Heinz
KHC
|
+$49.6M |
| 3 |
YPF Sociedad Anonima ADS
YPF
|
+$27.4M |
| 4 |
FRVO
Fervo Energy
FRVO
|
+$18.5M |
| 5 |
Comcast
CMCSA
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lear
LEA
|
+$69.6M |
| 2 |
Molson Coors Class B
TAP
|
+$50.9M |
| 3 |
Macy's
M
|
+$48.8M |
| 4 |
Sociedad Química y Minera de Chile
SQM
|
+$26.2M |
| 5 |
Vale
VALE
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 19.43% |
| 2 | Utilities | 14.9% |
| 3 | Communication Services | 9.91% |
| 4 | Consumer Discretionary | 9.6% |
| 5 | Technology | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Kadant
KAI
$3.51B
| $234K | 0.01% |
746
| – | – |
|
102
Copart
CPRT
$31.1B
| $208K | 0.01% |
7,386
| – | – |
|
103
AbbVie
ABBV
$460B
| – | – |
-3,126
| Closed | -$680K |
|
104
Abbott
ABT
$188B
| – | – |
-2,238
| Closed | -$230K |
|
105
Boston Scientific
BSX
$68B
| – | – |
-3,592
| Closed | -$225K |
|
106
CG Oncology
CGON
$6.59B
| – | – |
-3,295
| Closed | -$223K |
|
107
Dianthus Therapeutics
DNTH
$6.03B
| – | – |
-4,646
| Closed | -$390K |
|
108
EyePoint Inc
EYPT
$394M
| – | – |
-17,652
| Closed | -$228K |
|
109
Guardant Health
GH
$21.6B
| – | – |
-3,866
| Closed | -$357K |
|
110
Glaukos
GKOS
$10.6B
| – | – |
-2,197
| Closed | -$237K |
|
111
HCA Healthcare
HCA
$88.6B
| – | – |
-479
| Closed | -$227K |
|
112
IQVIA
IQV
$44.7B
| – | – |
-1,266
| Closed | -$216K |
|
|
LEG
113
DELISTED
Leggett & Platt
LEG
| – | – |
-10,246
| Closed | -$101K |
|
114
Eli Lilly
LLY
$1.03T
| – | – |
-772
| Closed | -$710K |
|
115
Mirum Pharmaceuticals
MIRM
$6.14B
| – | – |
-2,341
| Closed | -$216K |
|
116
SI-BONE Inc
SIBN
$835M
| – | – |
-14,710
| Closed | -$186K |
|
117
Scholar Rock
SRRK
$6.81B
| – | – |
-4,504
| Closed | -$221K |
|
|
STKL
118
DELISTED
SunOpta
STKL
| – | – |
-47,163
| Closed | -$306K |
|
119
Stantec
STN
$8.21B
| – | – |
-2,472
| Closed | -$213K |
|
120
Spyre Therapeutics
SYRE
$7.69B
| – | – |
-8,166
| Closed | -$412K |
|
|
121
Molson Coors Class B
TAP
$7.56B
| – | – |
-1,182,587
| Closed | -$50.9M |
|
122
Thermo Fisher Scientific
TMO
$229B
| – | – |
-718
| Closed | -$353K |
|
123
UnitedHealth
UNH
$360B
| – | – |
-856
| Closed | -$232K |
|
Similar funds
FFH
NSUP
PCG
TW
MIAS
LT
BB
RWC Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, RWC Asset Management held 181 positions worth $2.64B, up 10% from $2.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
RWC Asset Management's Q2 2026 filing shows 5 new, 49 increased, 33 reduced and 21 closed positions. Its largest new stake was J.M. Smucker: 1,555,311 shares worth $175M. The largest sale was Lear, an estimated $69.6M.
By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, up from 13% a quarter earlier, followed by Utilities and Communication Services.
- RWC Asset Management's largest Q2 2026 buy was J.M. Smucker: 1,555,311 shares worth $175M.
- RWC Asset Management added most to Kraft Heinz in Q2 2026, an estimated $49.6M increase.
- RWC Asset Management's biggest Q2 2026 reduction was Lear, cutting an estimated $69.6M.
- RWC Asset Management fully exited Molson Coors Class B in Q2 2026, selling an estimated $50.9M.
- RWC Asset Management's ten largest holdings make up 45% of its $2.64B portfolio in Q2 2026.
- RWC Asset Management opened 5 new positions and closed 21 in Q2 2026.
- RWC Asset Management's portfolio value rose 10% quarter-over-quarter to $2.64B.
Based on RWC Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.